Second-line treatment in patients with pancreatic ductal adenocarcinoma: A meta-analysis.

MLA

Sonbol, Mohamad Bassam, et al. “Second-Line Treatment in Patients with Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.” Cancer, vol. 123, no. 23, Dec. 2017, pp. 4680–86. EBSCOhost, https://doi.org/10.1002/cncr.30927.

APA

Sonbol, M. B., Firwana, B., Wang, Z., Almader-Douglas, D., Borad, M. J., Makhoul, I., Ramanathan, R. K., Ahn, D. H., & Bekaii-Saab, T. (2017). Second-line treatment in patients with pancreatic ductal adenocarcinoma: A meta-analysis. Cancer, 123(23), 4680–4686. https://doi.org/10.1002/cncr.30927

Chicago

Sonbol, Mohamad Bassam, Belal Firwana, Zhen Wang, Diana Almader-Douglas, Mitesh J Borad, Issam Makhoul, Ramesh K Ramanathan, Daniel H Ahn, and Tanios Bekaii-Saab. 2017. “Second-Line Treatment in Patients with Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.” Cancer 123 (23): 4680–86. doi:10.1002/cncr.30927.